Is Alcon Inc. a good investment? Alcon Inc. (ALC.SW) is currently trading at 55.18 CHF. Market analysts have a consensus price target of 74.81 CHF. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 50.92. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Alcon Inc. is expected to release its next earnings report on Nov. 10, 2026. The market consensus estimate for Forward EPS is 3.59.
For income investors, Alcon Inc. pays a dividend yield of 0.54%. With a payout ratio of 26%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.36 CHF (0.54% yield).
Alcon Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be Nov. 10, 2026. The company currently has a trailing EPS of 1.06.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.33 CHF
|
| May 12, 2027 (estimated) | 0.3303 |
| ▸2026 |
0.28 CHF
|
| May 7, 2026 | 0.2800 |
| ▸2025 |
0.28 CHF
|
| May 15, 2025 | 0.2800 |
| ▸2024 |
0.24 CHF
|
| May 16, 2024 | 0.2400 |
| ▸2023 |
0.21 CHF
|
| May 12, 2023 | 0.2100 |
| ▸2022 |
0.20 CHF
|
| May 5, 2022 | 0.2000 |
| ▸2021 |
0.10 CHF
|
| May 6, 2021 | 0.1000 |
| ▸2020 |
0.19 CHF
|
| May 12, 2020 | 0.1900 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Alcon Inc. | May 07, 2026 | Paid | 0.28 CHF |
Community Discussion